The number of shares owned by shareholders was adjusted after the market closes on Tuesday, February 13th 2018. View all of VXRT's competitors. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Vaxart's stock was trading at $2.07 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Identify stocks that meet your criteria using seven unique stock screeners. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. View our full suite of financial calendars and market data tables, all for free. Vote “Underperform” if you believe VXRT will underperform the S&P 500 over the long term. Amazon Stock Forecast 2028-2032 Only 17.90% of the stock of Vaxart is held by institutions. WARNING: Trend forecast is still in the development phase and should be used with caution. Vaxart, Inc. (NASDAQ:VXRT) posted its earnings results on Thursday, February, 25th. The company has a research collaboration agreement with Janssen Vaccines & Prevention B.V. (Janssen) to evaluate the company's proprietary oral vaccine platform for the Janssen universal influenza vaccine program. The biotechnology company reported ($0.13) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.08) by $0.05. Do Not Sell My Information. See more forecasts. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. As of 2021 March 08, Monday current price of VXRT stock is 6.005$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception).. Vaxart, Inc. has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame. Some companies that are related to Vaxart include Editas Medicine (EDIT), Sorrento Therapeutics (SRNE), NanoString Technologies (NSTG), Kymera Therapeutics (KYMR), BioCryst Pharmaceuticals (BCRX), Bavarian Nordic A/S (BVNRY), AlloVir (ALVR), bluebird bio (BLUE), Vericel (VCEL), Scholar Rock (SRRK), C4 Therapeutics (CCCC), Translate Bio (TBIO), REGENXBIO (RGNX), Krystal Biotech (KRYS) and Ocugen (OCGN). Vaxart had a negative net margin of 281.50% and a negative trailing twelve-month return on equity of 84.90%. On average, they anticipate Vaxart's share price to reach $15.00 in the next twelve months. Find real-time VXRT - Vaxart Inc stock quotes, company profile, news and forecasts from CNN Business. Company insiders that own Vaxart stock include Armistice Capital Master Fund, Armistice Capital, Llc, John P Richard, Michael J Finney, Sean Tucker, Todd C Davis and Wouter Latour. 2022 is $102.24, for Mar. It is also developing therapeutic immune-oncology vaccines for cervical cancer and dysplasia caused by human papillomavirus. Based on aggregate information from My MarketBeat watchlists, some companies that other Vaxart investors own include Inovio Pharmaceuticals (INO), Sorrento Therapeutics (SRNE), Dynavax Technologies (DVAX), VBI Vaccines (VBIV), Matinas BioPharma (MTNB), Bionano Genomics (BNGO), ADMA Biologics (ADMA), Novavax (NVAX), OrganiGram (OGI) and Novan (NOVN). Since then, VXRT shares have increased by 215.0% and is now trading at $6.52. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day! Amazon Stock Forecast 2023-2027. The P/E ratio of Vaxart is -11.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. View real-time stock prices and stock quotes for a full financial overview. Fundamental company data provided by Zacks Investment Research. In the past three months, Vaxart insiders have not sold or bought any company stock. Sign-up to receive the latest news and ratings for VXRT and its competitors with MarketBeat's FREE daily newsletter. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 High volatility in Vaxart stock price on Friday which ended trading at $6.02 (Updated on March 05, 2021) Sell candidate since 2021-02-16 Loss -25.59% PDF . Could Vaxart Be a Millionaire-Maker Stock? Looking for new stock ideas? Want to see which stocks are moving? Sanofi stock forecast for 05.03.2021. 03/07/2021. Should Investors Be Watching These Top Biotech Stocks This Month? Vaxart to Provide 2021 Business Outlook on Tuesday, March 2, 2021 - Yahoo Finance, view top-rated stocks among Wall Street analysts, Receive Analysts' Upgrades and Downgrades Daily. Terms of Use and Privacy Policy. - Yahoo Finance. Please log in to your account or sign up in order to add this asset to your watchlist. Vaxart has received a consensus rating of Buy. (Add your “underperform” vote.). VXRT stock forecasts by analyst. Tesla stock price stood at $597.95. VXRT Stock Analysis Overview What this means: InvestorsObserver gives Vaxart Inc (VXRT) an overall rank of 41, which is below average. Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. Its Palantir stock forecast 2025 has the company trading at $348.78 per share, up from an average of $78.46 in December 2021. MarketBeat's community ratings are surveys of what our community members think about Vaxart and other stocks. According to the latest long-term forecast, Tesla price will hit $800 by the end of 2021 and then $1,300 by the end of 2022. Find the latest Vaxart, Inc. - Common Stock (VXRT) stock discussions in Yahoo Finance's forum. The official website for Vaxart is www.vaxart.com. View which stocks are hot on social media with MarketBeat's trending stocks report. View insider buying and selling activity for Vaxart or or view top insider-buying stocks. Could Vaxart Be a Millionaire-Maker Stock? © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. VAXART, INC. (VXRT) Moves 5.6% Higher: Will This Strength Last? Their forecasts range from $13.00 to $17.00. Year’s end. This is why we are offering FREE 14 days TRIAL SUBSCRIPTIONS with no further commitments. 2 analysts have issued 1-year price objectives for Vaxart's shares. In the short term (2weeks), VXRT's stock price should outperform the market by 0.87%.During that period the price should oscillate between -12.74% and +17.02%.. Estimated Average Forecasted Sanofi Price: 46.64 Positive intraday dynamics of the instrument is expected with 2.973% volatility is expected. 2021 is $70.69, for Mar. Access to Intraday penny stock screener Scan for strong stocks Never miss a profitable trade. Vaxart has only been the subject of 1 research reports in the past 90 days. Vaxart Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. Should I buy or sell VXRT stock? VXRT Stock Predictions. We are all together in this COVID-19 pandemic. View our earnings forecast for Vaxart. Online stock forecasting service Wallet Investor is very optimistic about the stock’s long-term future. All rights reserved. Tyson Foods stock forecast for 02.03.2021. The biotechnology company can be reached via phone at (650) 550-3500 or via email at [email protected]. With a year-over-year growth in debt of 211.63%, Vaxart Inc's debt growth rate surpasses 93.9% of about US stocks.
Days Of 76 Campground Map, Harpeth Square Franklin Tn, Studienkolleg Bochum Aufnahmeprüfung, Biggie Smalls Documentary 2020, Amazon Corporate Headquarters Seattle, The Hitchhikers Guide To The Galaxy Summary Pdf, Where Was Hamilton Shot On His Body, Jason Rogel The Office, Amazon Headquarters Virginia,